Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep

European Respiratory Review

Volumn 16, Issue 106, 2007, Pages 115-124

  Pevernagie, D ^a   Janssens, J P ^c   De Backer, W ^b   Elliott, M ^d   Pepperell, J ^e   Andrease, S ^f  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Service of Pneumology   (Belgium)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

^f Lungenfachklinik Immenhausen   (Germany)

Author keywords

Bi level positive airway pressure; Central sleep apnoea; Continuous positive airway pressure; Hypoventilation; Pharmacological treatment; Sleep disordered breathing

Indexed keywords

ACETAZOLAMIDE; CARBON DIOXIDE; OXYGEN; THEOPHYLLINE;

AIRWAY PRESSURE; ARTIFICIAL VENTILATION; CHEYNE STOKES BREATHING; CLINICAL TRIAL; CONFERENCE PAPER; COR PULMONALE; HEART FAILURE; HUMAN; LIFE EXPECTANCY; LUNG ALVEOLUS HYPOVENTILATION; NEUROLOGIC DISEASE; OBESITY; OBESITY HYPOVENTILATION SYNDROME; PRESSURE SUPPORT VENTILATION; PULMONARY HYPERTENSION; SLEEP APNEA SYNDROME;

EID: 37349116959     PISSN: 09059180     EISSN: None     Source Type: Journal    
DOI: 10.1183/09059180.00010602     Document Type: Conference Paper

References (80)

1. Sharp JT, Barrocas M, Chokroverty S. The cardiorespiratory effects of obesity. Clin Chest Med 1980; 1: 103-118.
2. Skatrud JB, Dempsey JA. Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J Appl Physiol 1983; 55: 813-822.
3. De Backer WA. Central sleep apnoea, pathogenesis and treatment: an overview and perspective. Eur Respir J 1995; 8: 1372-1383.
4. De Backer WA. Sleep and breathing: actual insight and perspectives. Eur Respir J 1995; 8: 1071-1072.
5. De Backer WA. Methods and clinical significance of studying chemical drives. Respir Physiol 1998; 114: 75-81.
6. Badr MS, Toiber F, Skatrud JB, Dempsey J. Pharyngeal narrowing/occlusion during central sleep apnea. J Appl Physiol 1995; 78: 1806-1815.
7. Vanderveken OM, Oostveen E, Boudewyns AN, Verbraecken JA, Van de Heyning PH, De Backer WA. Quantification of pharyngeal patency in patients with sleep-disordered breathing. ORL J Otorhinolaryngol Relat Spec 2005; 67: 168-179.
8. De Backer W. Upper airway reflexes and obstructive sleep apnoea. Eur Respir J 1993; 6: 9-10.
9. Javaheri S. Central sleep apnea-hypopnea syndrome in heart failure: prevalence, impact, and treatment. Sleep 1996; 19: Suppl. 10, S229-S231.
10. Kohnlein T, Welte T, Tan LB, Elliott MW. Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax 2002; 57: 547-554.
11. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998; 97: 2154-2159.
12. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160: 1101-1106.
13. Andreas S. Nocturnal insights in chronic heart failure. Eur Heart J 1999; 20: 1140-1141.
14. 2 drive in patients with obstructive sleep apnea and effect of CPAP. Respir Physiol 1995; 101: 279-287.
15. 2) drive in patients with obstructive sleep apnea. Respir Physiol 2000; 123: 121-130.
16. Biberdorf DJ, Steens R, Millar TW, Kryger MH. Benzodiazepines in congestive heart failure: effects of temazepam on arousability and Cheyne-Stokes respiration. Sleep 1993; 16: 529-538.
17. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, 1996; pp. 672-682.
18. Funaya H, Kitakaze M, Node K, Minamino T, Komamura K, Hori M. Plasma adenosine levels increase in patients with chronic heart failure. Circulation 1997; 95: 1363-1365.
19. Engelstein ED, Lerman BB, Somers VK, Rea RF. Role of arterial chemoreceptors in mediating the effects of endogenous adenosine on sympathetic nerve activity. Circulation 1994; 90: 2919-2926.
20. Andreas S, Reiter H, Luthje L, et al. Differential effects of theophylline on sympathetic excitation, hemodynamics, and breathing in congestive heart failure. Circulation 2004; 110: 2157-2162.
21. Javaheri S, Parker TJ, Wexler L, Liming JD, Lindower P, Roselle GA. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996; 335: 562-567.
22. Pesek CA, Cooley R, Narkiewicz K, Dyken M, Weintraub NL, Somers VK. Theophylline therapy for near-fatal Cheyne-Stokes respiration. A case report. Ann Intern Med 1999; 130: 427-430.
23. De Backer WA, Verbraecken J, Willemen M, Wittesaele W, De Cock W, Van de Heyning P. Central apnea index decreases after prolonged treatment with acetazolamide. Am J Respir Crit Care Med 1995; 151: 87-91.
24. Sutton JR, Houston CS, Mansell AL, et al. Effect of acetazolamide on hypoxemia during sleep at high altitude. N Engl J Med 1979; 301: 1329-1331.
25. Nakayama H, Smith CA, Rodman JR, Skatrud JB, Dempsey JA. Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep. Am J Respir Crit Care Med 2002; 165: 1251-1260.
26. Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 2006; 173: 234-237.
27. Krachman SL, D'Alonzo GE, Berger TJ, Eisen HJ. Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne-Stokes respiration during sleep in congestive heart failure. Chest 1999; 116: 1550-1557.
28. Walsh JT, Andrews R, Starling R, Cowley AJ, Johnston ID, Kinnear WJ. Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. Br Heart J 1995; 73: 237-241.
29. Hanly PJ, Millar TW, Steljes DG, Baert R, Frais MA, Kryger MH. The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 1989; 111: 777-782.
30. Andreas S, von zur Mühlen F, Stevens J, Kreuzer H. Nocturnal oxygen and hypercapnic ventilatory response in patients with congestive heart failure. Respir Med 1998; 92: 426-431.
31. 2 on sleep-related disordered breathing in ambulatory patients with stable heart failure. Sleep 1999; 22: 1101-1106.
32. Staniforth AD, Kinnear WJ, Starling R, Hetmanski DJ, Cowley AJ. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998; 19: 922-928.
33. Arzt M, Schulz M, Wensel R, et al. Nocturnal continuous positive airway pressure improves ventilatory efficiency during exercise in patients with chronic heart failure. Chest 2005; 127: 794-802.
34. Sasayama S, Izumi T, Seino Y, Ueshima K, Asanoi H. Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and Cheyne-Stokes respiration. Circ J 2006; 70: 1-7.
35. Franklin KA, Eriksson P, Sahlin C, Lundgren R. Reversal of central sleep apnea with oxygen. Chest 1997; 111: 163-169.
36. Mak S, Azevedo ER, Liu PP, Newton GE. Effect of hyperoxia on left ventricular function and filling pressures in patients with and without congestive heart failure. Chest 2001; 120: 467-473.
37. Haque WA, Boehmer J, Clemson BS, Leuenberger UA, Silber DH, Sinoway LI. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol 1996; 27: 353-357.
38. Andreas S, Weidel K, Hagenah G, Heindl S. Treatment of Cheyne-Stokes respiration with nasal oxygen and carbon dioxide. Eur Respir J 1998; 12: 414-419.
39. 2 in heart failure. Am J Respir Crit Care Med 1994; 150: 1598-1604.
40. Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995; 152: 473-479.
41. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102: 61-66.
42. Willson GN, Wilcox I, Piper AJ, et al. Noninvasive pressure preset ventilation for the treatment of Cheyne-Stokes respiration during sleep. Eur Respir J 2001; 17: 1250-1257.
43. Kasai T, Narui K, Dohi T, et al. Efficacy of nasal bi-level positive airway pressure in congestive heart failure patients with Cheyne-Stokes respiration and central sleep apnea. Circ J 2005; 69: 913-921.
44. Kohnlein T, Welte T, Tan LB, Elliott MW. Assisted ventilation for heart failure patients with Cheyne-Stokes respiration. Eur Respir J 2002; 20: 934-941.
45. Bradley TD, Logan AG, Kimoff RJ, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005; 353: 2025-2033.
46. Liston R, Deegan PC, McCreery C, Costello R, Maurer B, McNicholas WT. Haemodynamic effects of nasal continuous positive airway pressure in severe congestive heart failure. Eur Respir J 1995; 8: 430-435.
47. Gabor JY, Newman DA, Barnard-Roberts V, et al. Improvement in Cheyne-Stokes respiration following cardiac resynchronisation therapy. Eur Respir J 2005; 26: 95-100.
48. Sinha AM, Skobel EC, Breithardt OA, et al. Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 2004; 44: 68-71.
49. Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004; 169: 361-366.
50. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233-1241.
51. Mayer J, Weichler U, Herres-Mayer B, Schneider H, Marx U, Peter JH. Influence of metoprolol and cilazapril on blood pressure and on sleep apnea activity. J Cardiovasc Pharmacol 1990; 16: 952-961.
52. Weichler U, Herres-Mayer B, Mayer J, Weber K, Hoffmann R, Peter JH. Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity. Cardiology 1991; 78: 124-130.
53. Dark DS, Pingleton SK, Kerby GR, et al. Breathing pattern abnormalities and arterial oxygen desaturation during sleep in the congestive heart failure syndrome. Improvement following medical therapy. Chest 1987; 91: 833-836.
54. Tomcsanyi J, Karlocai K, Papp L. Disappearance of periodic breathing after heart operations. J Thorac Cardiovasc Surg 1994; 107: 317-318.
55. Topfer V, El Sebai M, Wessendorf TE, Moraidis I, Teschler H. Adaptive servoventilation: effect on Cheyne-Stokes respiration and on quality of life. Pneumologie 2004; 58: 28-32.
56. Schadlich S, Konigs I, Kalbitz F, Blankenburg T, Busse HJ, Schutte W. Cardiac efficiency in patients with Cheyne-Stokes respiration as a result of heart insufficiency during long-term nasal respiratory treatment with adaptive servo ventilation (AutoSet CS). Z Kardiol 2004; 93: 454-462.
57. Teschler H, Dohring J, Wang YM, Berthon-Jones M. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001; 164: 614-619.
58. Vogt-Ladner G, Worth H, Schacher C, Vogt M, Teschler H. Nasal ventilation with Autoset-CS versus nocturnal oxygen therapy (NOT) in patients with severe chronic heart failure (CHF) and Cheyne-Stokes respiration (CSR): long term effects on quality of sleep. Am J Respir Crit Care Med 2003; 167: A836.
59. Pepperell JC, Maskell NA, Jones DR, et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 2003; 168: 1109-1114.
60. Philippe C, Stoica-Herman M, Drouot X, et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 2006; 92: 337-342.
61. Nowbar S, Burkart KM, Gonzales R, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med 2004; 116: 1-7.
62. Janssens JP, Derivaz S, Breitenstein E, et al. Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area. Chest 2003; 123: 67-79.
63. Leger P, Bedicam JM, Cornette A, et al. Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency. Chest 1994; 105: 100-105.
64. Simonds AK, Elliott MW. Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. Thorax 1995; 50: 604-609.
65. Schönhofer B, Sonneborn M, Haidl P, Bohrer H, Kohler D. Comparison of two different modes for noninvasive mechanical ventilation in chronic respiratory failure: volume versus pressure controlled device. Eur Respir J 1997; 10: 184-191.
66. Eichholzer M, Luthy J, Gutzwiller F. Epidemiology of overweight in Switzerland: results of the Swiss National Health Survey 1992-93. Schweiz Med Wochenschr 1999; 129: 353-361.
67. Seidell JC. Obesity in Europe: scaling an epidemic. Int J Obes Relat Metab Disord 1995; 19: Suppl. 3, S1-S4.
68. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998; 22: 39-47.
69. Redolfi S, Corda L, La Piana G, Spandrio S, Prometti P, Tantucci C. Long-term non-invasive ventilation increases chemosensitivity and leptin in obesity-hypoventilation syndrome. Respir Med 2007; 101: 1191-1195.
70. Chouri-Pontarollo N, Borel JC, Tamisier R, Wuyam B, Levy P, Pepin JL. Impaired objective daytime vigilance in obesity-hypoventilation syndrome: impact of noninvasive ventilation. Chest 2007; 131: 148-155.
71. Pankow W, Hijjeh N, Schuttler F, et al. Influence of noninvasive positive pressure ventilation on inspiratory muscle activity in obese subjects. Eur Respir J 1997; 10: 2847-2852.
72. Sullivan CE, Berthon-Jones M, Issa FG. Remission of severe obesity-hypoventilation syndrome after short-term treatment during sleep with nasal continuous positive airway pressure. Am Rev Respir Dis 1983; 128: 177-181.
73. Sanders MH, Kern N. Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask. Physiologic and clinical implications. Chest 1990; 98: 317-324.
74. Bott J, Baudouin SV, Moxham J. Nasal intermittent positive pressure ventilation in the treatment of respiratory failure in obstructive sleep apnoea. Thorax 1991; 46: 457-458.
75. Piper AJ, Sullivan CE. Effects of short-term NIPPV in the treatment of patients with severe obstructive sleep apnea and hypercapnia. Chest 1994; 105: 434-440.
76. Perez de Llano LA, Golpe R, Ortiz PM, et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest 2005; 128: 587-594.
77. Masa JF, Celli BR, Riesco JA, Hernandez M, Sanchez DC, Disdier C. The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation. Chest 2001; 119: 1102-1107.
78. Resta O, Guido P, Picca V, et al. Prescription of nCPAP and nBIPAP in obstructive sleep apnoea syndrome: Italian experience in 105 subjects. A prospective two centre study. Respir Med 1998; 92: 820-827.
79. Rabec C, Merati M, Baudouin N, Foucher P, Ulukavac T, Reybet-Degat O. Management of obesity and respiratory insufficiency. The value of dual-level pressure nasal ventilation. Rev Mal Respir 1998; 15: 269-278.
80. Schäfer H, Ewig S, Hasper E, Luderitz B. Failure of CPAP therapy in obstructive sleep apnoea syndrome: predictive factors and treatment with bilevel-positive airway pressure. Respir Med 1998; 92: 208-215.